| P2093 | author name string | José Miñarro | |
| | Marta Rodríguez-Arias | |
| | Luis Stinus | |
| | Isolde Broseta | |
| P2860 | cites work | Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice | Q28370864 |
| | Effects of SCH 23390, raclopride, and haloperidol on morphine withdrawal-induced aggression in male mice | Q28373126 |
| | Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. | Q41042454 |
| | Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 |
| | Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal | Q41211959 |
| | Effects of ondansetron administration on opioid withdrawal syndrome observed in rats | Q42543676 |
| | Continuous quantitative monitoring of spontaneous opiate withdrawal: locomotor activity and sleep disorders | Q42545425 |
| | Role of cerebral dopamine and noradrenaline in the morphine-induced locomotor sensitisation in mice | Q42547644 |
| | Previous chronic blockade of NMDA receptors intensifies morphine dependence in rats | Q43310982 |
| | Effect of adenosine receptor agonists and antagonists on the expression of opiate withdrawal in rats | Q43331943 |
| | Effects of tizanidine on morphine physical dependence: attenuation and intensification | Q43741268 |
| | Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs | Q44337557 |
| | Involvement of delta 1 and delta 2 opioid receptor subtypes in the development of physical dependence on morphine in mice | Q44345838 |
| | Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors | Q48162316 |
| | Modifications of striatal D2 dopaminergic postsynaptic sensitivity during development of morphine tolerance-dependence in mice | Q48428393 |
| | Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy | Q48729145 |
| | Involvement of locus coeruleus projections in opiate withdrawal but not in opiate tolerance in mice | Q48960755 |
| | Chronic neurosteroid treatment prevents the development of morphine tolerance and attenuates abstinence behavior in mice. | Q51533687 |
| | Diazepam pretreatment suppresses morphine withdrawal signs in the mouse. | Q51584907 |
| | Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score". | Q52204816 |
| | Intracisternal administration of interleukin-1β attenuates naloxone-precipitated withdrawal in morphine-dependent mice | Q60728455 |
| | Influence of different benzodiazepines on the experimental morphine abstinence syndrome | Q67649873 |
| | Influence of psychogenetics in opiate tolerance and abstinence in mice | Q68038116 |
| | Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats | Q69702618 |
| | Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice | Q70473087 |
| | Study of the mechanisms involved in behavioral changes induced by flunitrazepam in morphine withdrawal | Q70831366 |
| | Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs | Q71350111 |
| | Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice | Q71677745 |
| | Regional differences in cerebral noradrenaline turnover in mice withdrawn from repeated morphine treatment and tolerance to the effects of acute morphine | Q71712712 |
| | Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine | Q71760182 |
| | Diltiazem inhibits naloxone-precipitated and spontaneous morphine withdrawal in rats | Q71942968 |
| | Opiate withdrawal intensity correlates with the presence of DSLET high-affinity binding | Q72620754 |
| | Riluzole decreases the abstinence syndrome and physical dependence in morphine-dependent mice | Q73024981 |
| | The influence of chronic treatment with clonidine, yohimbine and idazoxan on morphine withdrawal | Q73629621 |
| | Antinociception, tolerance, and physical dependence comparison between morphine and tramadol | Q77514243 |
| | Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation | Q77725766 |
| | Acutely administered clozapine does not modify naloxone-induced withdrawal jumping in morphine-dependent mice | Q78107670 |
| P433 | issue | 2 | |
| P921 | main subject | morphine | Q81225 |
| P304 | page(s) | 335-347 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Progress in Neuro-Psychopharmacology & Biological Psychiatry | Q15616665 |
| P1476 | title | Ethological analysis of morphine withdrawal with different dependence programs in male mice | |
| P478 | volume | 26 | |